234 related articles for article (PubMed ID: 33222205)
1. Cryo-electron microscopy of cholinesterases, present and future.
Leung MR; Zeev-Ben-Mordehai T
J Neurochem; 2021 Sep; 158(6):1236-1243. PubMed ID: 33222205
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of the native butyrylcholinesterase tetramer reveals a dimer of dimers stabilized by a superhelical assembly.
Leung MR; van Bezouwen LS; Schopfer LM; Sussman JL; Silman I; Lockridge O; Zeev-Ben-Mordehai T
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13270-13275. PubMed ID: 30538207
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
4. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
6. New data on the structure of the acyl pocket in cholinesterases.
Moralev SN
Dokl Biochem; 2000; 375():215-7. PubMed ID: 11296473
[No Abstract] [Full Text] [Related]
7. The origin of the molecular diversity and functional anchoring of cholinesterases.
Massoulié J
Neurosignals; 2002; 11(3):130-43. PubMed ID: 12138250
[TBL] [Abstract][Full Text] [Related]
8. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
Chen X; Tikhonova IG; Decker M
Bioorg Med Chem; 2011 Feb; 19(3):1222-35. PubMed ID: 21232964
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel phosphorothioates and phosphorodithioates and their differential inhibition of cholinesterases.
Kaboudin B; Emadi S; Hadizadeh A
Bioorg Chem; 2009 Aug; 37(4):101-5. PubMed ID: 19481235
[TBL] [Abstract][Full Text] [Related]
10. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
[TBL] [Abstract][Full Text] [Related]
11. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
12. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors.
Mughal EU; Javid A; Sadiq A; Murtaza S; Zafar MN; Khan BA; Sumrra SH; Tahir MN; Kanwal ; Khan KM
Bioorg Med Chem; 2018 Jul; 26(12):3696-3706. PubMed ID: 29886083
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
[No Abstract] [Full Text] [Related]
15. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
[TBL] [Abstract][Full Text] [Related]
16. Novel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profile.
Strelnik AD; Petukhov AS; Zueva IV; Zobov VV; Petrov KA; Nikolsky EE; Balakin KV; Bachurin SO; Shtyrlin YG
Bioorg Med Chem Lett; 2016 Aug; 26(16):4092-4. PubMed ID: 27377327
[TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of sensitivity of cholinesterase inhibitors by multidimensional statistical methods].
Moralev SN; Perchenok AIu
Zh Evol Biokhim Fiziol; 2008; 44(5):488-91. PubMed ID: 18959211
[TBL] [Abstract][Full Text] [Related]
18. Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis.
Wong KK; Ngo JC; Liu S; Lin HQ; Hu C; Shaw PC; Wan DC
Chem Biol Interact; 2010 Sep; 187(1-3):335-9. PubMed ID: 20350537
[TBL] [Abstract][Full Text] [Related]
19. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by methylene violet 3RAX.
Onder S; Biberoglu K; Tacal O
Chem Biol Interact; 2019 Dec; 314():108845. PubMed ID: 31593690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
